Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants

Italian Journal of Pediatrics ◽

10.1186/1824-7288-35-4 ◽

2009 ◽

Vol 35 (1) ◽

pp. 4 ◽

Author(s):

Gaetano Chirico ◽

Roberto Ravasio ◽

Urbano Sbarigia

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Simulation Model ◽

Preterm Infants ◽

Respiratory Syncytial Virus Infection ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Syncytial Virus

Download Full-text

Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain

BMC Infectious Diseases ◽

10.1186/s12879-017-2803-0 ◽

2017 ◽

Vol 17 (1) ◽

Author(s):

M. Sanchez-Luna ◽

R. Burgos-Pol ◽

I. Oyagüez ◽

J. Figueras-Aloy ◽

M. Sánchez-Solís ◽

...

Keyword(s):

Respiratory Syncytial Virus ◽

Virus Infection ◽

Preterm Infants ◽

Respiratory Syncytial Virus Infection ◽

Clinical Evidence ◽

Cost Utility ◽

Cost Utility Analysis ◽

Infection Prophylaxis ◽

Utility Analysis ◽

Syncytial Virus

Download Full-text

A Novel Six Consecutive Monthly Doses of Palivizumab Prophylaxis Protocol for the Prevention of Respiratory Syncytial Virus Infection in High-Risk Preterm Infants in Taiwan

PLoS ONE ◽

10.1371/journal.pone.0100981 ◽

2014 ◽

Vol 9 (6) ◽

pp. e100981 ◽

Author(s):

Hsin Chi ◽

Chyong-Hsin Hsu ◽

Jui-Hsing Chang ◽

Nan-Chang Chiu ◽

Han-Yang Hung ◽

...

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Preterm Infants ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus

Download Full-text

Faculty Opinions recommendation of Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13356007.14726117 ◽

2011 ◽

Author(s):

Daniel Sloniewsky

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Literature Review ◽

Respiratory Syncytial Virus Infection ◽

Systematic Literature Review ◽

Meta Analysis ◽

Severe Respiratory Syncytial Virus ◽

Mortality And Morbidity ◽

Syncytial Virus

Download Full-text

Severe Respiratory Syncytial Virus Infection in Preterm Infants and Later Onset of Asthma

The Pediatric Infectious Disease Journal ◽

10.1097/inf.0000000000002432 ◽

2019 ◽

Vol 38 (11) ◽

pp. 1121-1125 ◽

Author(s):

Matthew B. Jalink ◽

Joanne M. Langley ◽

Linda Dodds ◽

Pantelis Andreou

Keyword(s):

Respiratory Syncytial Virus ◽

Virus Infection ◽

Preterm Infants ◽

Respiratory Syncytial Virus Infection ◽

Severe Respiratory Syncytial Virus ◽

Syncytial Virus

Download Full-text

Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults

New England Journal of Medicine ◽

10.1056/nejmoa043951 ◽

2005 ◽

Vol 352 (17) ◽

pp. 1749-1759 ◽

Cited By ~ 1087

Author(s):

Ann R. Falsey ◽

Patricia A. Hennessey ◽

Maria A. Formica ◽

Christopher Cox ◽

Edward E. Walsh

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus

Download Full-text

The role of RSV neutralizing antibodies in the treatment and prevention of respiratory syncytial virus infection in high-risk children

Antiviral Research ◽

10.1016/0166-3542(94)90028-0 ◽

1994 ◽

Vol 23 (1) ◽

pp. 1-10 ◽

Author(s):

Jessie R. Groothuis

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Neutralizing Antibodies ◽

Treatment And Prevention ◽

Syncytial Virus ◽

High Risk Children

Download Full-text

Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort

Archives of Disease in Childhood ◽

10.1136/adc.83.4.313 ◽

2000 ◽

Vol 83 (4) ◽

pp. 313-316 ◽

Author(s):

S. J Clark

Keyword(s):

United Kingdom ◽

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Potential Impact ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Is Clinical Recognition of Respiratory Syncytial Virus Infection in Hospitalized Elderly and High‐Risk Adults Possible?

The Journal of Infectious Diseases ◽

10.1086/511986 ◽

2007 ◽

Vol 195 (7) ◽

pp. 1046-1051 ◽

Author(s):

Edward E. Walsh ◽

Derick R. Peterson ◽

Ann R. Falsey

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Hospitalized Elderly ◽

Syncytial Virus

Download Full-text

Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants

10.1542/peds.102.3.531 ◽

1998 ◽

Vol 102 (3) ◽

pp. 531-537 ◽

Cited By ~ 1251

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Editorial - Respiratory Syncytial Virus Infection in High-Risk Infants

The Open Microbiology Journal ◽

10.2174/1874285801105010127 ◽

2011 ◽

Vol 5 (1) ◽

pp. 127-127

Author(s):

Bernhard Resch

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text